JP2008542386A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008542386A5 JP2008542386A5 JP2008514814A JP2008514814A JP2008542386A5 JP 2008542386 A5 JP2008542386 A5 JP 2008542386A5 JP 2008514814 A JP2008514814 A JP 2008514814A JP 2008514814 A JP2008514814 A JP 2008514814A JP 2008542386 A5 JP2008542386 A5 JP 2008542386A5
- Authority
- JP
- Japan
- Prior art keywords
- och
- conh
- aryl
- chco
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US68658505P | 2005-06-02 | 2005-06-02 | |
| US60/686,585 | 2005-06-02 | ||
| PCT/US2006/021142 WO2006130707A2 (en) | 2005-06-02 | 2006-06-01 | Mao-b inhibitors useful for treating obesity |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008542386A JP2008542386A (ja) | 2008-11-27 |
| JP2008542386A5 true JP2008542386A5 (enExample) | 2012-07-12 |
| JP5253155B2 JP5253155B2 (ja) | 2013-07-31 |
Family
ID=37482280
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008514814A Expired - Fee Related JP5253155B2 (ja) | 2005-06-02 | 2006-06-01 | 肥満治療に有用なｍａｏ−ｂ阻害剤 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7649115B2 (enExample) |
| EP (1) | EP1890690A4 (enExample) |
| JP (1) | JP5253155B2 (enExample) |
| CN (1) | CN101300006B (enExample) |
| AU (1) | AU2006252540B2 (enExample) |
| CA (1) | CA2620476A1 (enExample) |
| IL (1) | IL187825A (enExample) |
| NZ (1) | NZ564130A (enExample) |
| WO (1) | WO2006130707A2 (enExample) |
| ZA (1) | ZA200800036B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI361075B (en) * | 2007-03-16 | 2012-04-01 | Brion Res Inst Of Taiwan | Pharmaceutical composition for inhibiting the syndrome of snore |
| EP2053033A1 (en) * | 2007-10-26 | 2009-04-29 | Bayer Schering Pharma AG | Compounds for use in imaging, diagnosing and/or treatment of diseases of the central nervous system or of tumors |
| IT1392914B1 (it) * | 2009-01-22 | 2012-04-02 | Dipharma Francis Srl | Procedimento per la preparazione di (r)-n-propargil-1-amminoindano e suoi sali |
| KR102007633B1 (ko) | 2016-12-15 | 2019-08-06 | 일동제약(주) | 신규 페닐 프로피온 산 유도체 및 이의 용도 |
| CN107056630B (zh) * | 2017-01-23 | 2020-01-17 | 合肥工业大学 | 一种茚满类衍生物及其合成方法和在医药上的用途 |
| BR112020005489A2 (pt) | 2017-09-22 | 2020-09-24 | Jubilant Epipad Llc, | composto da fórmula (i), composto de fórmula (ii), composto de fórmula (iii), processo de preparação de compostos de fórmula (i), processo de preparação de compostos de fórmula (ii), processo de preparação de compostos de fórmula (iii), composição farmacêutica, método para inibir uma ou mais famílias pad em uma célula, método para tratar uma afeção mediada por um ou mais pads, utilização do composto, método para o tratamento e/ou prevenção de uma afeção mediada por um ou mais distúrbios da família pad, método para o tratamento de artrite reumatoide e método de tratamento de câncer |
| CN111225915B (zh) | 2017-10-18 | 2023-03-07 | 朱比兰特埃皮帕德有限公司 | 作为pad抑制剂的咪唑并吡啶化合物 |
| EP3707135A1 (en) | 2017-11-06 | 2020-09-16 | Jubilant Prodel LLC | Pyrimidine derivatives as inhibitors of pd1/pd-l1 activation |
| IL274762B2 (en) | 2017-11-24 | 2023-10-01 | Jubilant Episcribe Llc | Novel heterocyclic compounds as prmt5 inhibitors |
| EP3765453A1 (en) | 2018-03-13 | 2021-01-20 | Jubilant Prodel LLC | Bicyclic compounds as inhibitors of pd1/pd-l1 interaction/activation |
| WO2022269439A1 (en) * | 2021-06-21 | 2022-12-29 | Ildong Pharmaceutical Co., Ltd. | Method of controlling blood sugar level and treatment of diabetes and related conditions |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3201470A (en) | 1965-08-17 | Chsx c cech | ||
| US3253037A (en) | 1962-06-19 | 1966-05-24 | Ciba Geigy Corp | N-2-alkynyl-amino-benzocylo-alkanes |
| GB1187017A (en) | 1966-07-16 | 1970-04-08 | Aspro Nicholas Ltd | Substituted 1-Amino Indanes and Tetrahydronaphthalens |
| IL92952A (en) * | 1990-01-03 | 1994-06-24 | Teva Pharma | R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them |
| IL99759A (en) * | 1991-10-16 | 1997-06-10 | Teva Pharma | Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them |
| US5914349A (en) | 1994-01-10 | 1999-06-22 | Teva Pharmaceutical Industries, Ltd. | Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| ZA96211B (en) | 1995-01-12 | 1996-07-26 | Teva Pharma | Compositions containing and methods of using 1- aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
| PT966435E (pt) | 1996-12-18 | 2005-06-30 | Yissum Res Dev Co | Derivados aminoindano |
| EP1078632A1 (en) * | 1999-08-16 | 2001-02-28 | Sanofi-Synthelabo | Use of monoamine oxydase inhibitors for the manufacture of drugs intended for the treatment of obesity |
| DE10142667B4 (de) * | 2001-08-31 | 2004-06-09 | Aventis Pharma Deutschland Gmbh | C2-substituierte Indan-1-ole und ihre Derivate und ihre Verwendung als Arzneimittel |
| IL162308A0 (en) * | 2001-12-21 | 2005-11-20 | Lundbeck & Co As H | Aminoindane derivatives as serotonin and norepinephrine uptakeinhibitors |
| WO2003072055A2 (en) * | 2002-02-27 | 2003-09-04 | Teva Pharmaceutical Industries, Ltd. | Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective mao inhibitors |
| US20040010038A1 (en) | 2002-02-27 | 2004-01-15 | Eran Blaugrund | Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors |
| EP1686973A4 (en) * | 2003-11-25 | 2009-03-25 | Technion Res & Dev Foundation | COMPOSITIONS AND METHODS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES AND DISEASES |
| WO2005084205A2 (en) * | 2004-02-27 | 2005-09-15 | Teva Pharmaceutical Industries, Ltd. | Diamino thiazoloindan derivatives and their use |
| US20050197365A1 (en) * | 2004-02-27 | 2005-09-08 | Jeffrey Sterling | Diamino thiazoloindan derivatives and their use |
| JP2008531546A (ja) | 2005-02-22 | 2008-08-14 | テバ ファーマシューティカル インダストリーズ リミティド | エナンチオマー性インダニルアミン誘導体の合成のための改良されたプロセス |
-
2006
- 2006-06-01 CA CA002620476A patent/CA2620476A1/en not_active Abandoned
- 2006-06-01 EP EP06771748A patent/EP1890690A4/en not_active Withdrawn
- 2006-06-01 WO PCT/US2006/021142 patent/WO2006130707A2/en not_active Ceased
- 2006-06-01 US US11/445,044 patent/US7649115B2/en not_active Expired - Fee Related
- 2006-06-01 JP JP2008514814A patent/JP5253155B2/ja not_active Expired - Fee Related
- 2006-06-01 NZ NZ564130A patent/NZ564130A/en not_active IP Right Cessation
- 2006-06-01 AU AU2006252540A patent/AU2006252540B2/en not_active Ceased
- 2006-06-01 CN CN2006800273036A patent/CN101300006B/zh not_active Expired - Fee Related
-
2007
- 2007-12-02 IL IL187825A patent/IL187825A/en not_active IP Right Cessation
-
2008
- 2008-01-02 ZA ZA200800036A patent/ZA200800036B/xx unknown
-
2009
- 2009-12-31 US US12/650,642 patent/US8541475B2/en not_active Expired - Fee Related